Neuroimaging Findings in Toxic Brain Injuries
The neurotoxic effects of various drugs and metabolites are often overlooked in the larger picture of complex medical problems. However, with the advent of novel MR imaging techniques, these neurologic effects are being increasingly recognized. These agents include exogenous and endogenous
metabolites, and their manifestations may be subtle to recognize. The reversibility of their neurotoxic effects depends on prompt radiologic recognition of the neuroimaging findings to alert the ordering physicians and to initiate appropriate therapy. In this article, the neurotoxic potential
of various metabolites is presented and their MR imaging findings are summarized.
Keywords: ADC = apparent diffusion coefficient; CNS = central nervous system; DKA = diabetic ketoacidosis; DWI = diffusion-weighted imaging; FLAIR = fluid-attenuated inversion recovery; GRE = gradient-recalled echo; MBD = Marchiafava-Bignami disease; MELAS = mitochondrial encephalopathy, lactic acidosis, and strokelike episodes; MTX = methotrexate; ODMS = osmotic demyelination syndrome; PRES = posterior reversible encephalopathy syndrome; TIWI = T1-weighted imaging; WE = Wernicke encephalopathy
Document Type: Research Article
Publication date: June 1, 2012
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content